Clinical Trials | April 14, 2026
AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Highlights Mirvetuximab-based regimen promise
Highlights Mirvetuximab-based regimen promise
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Subscribe To Our Newsletter & Stay Updated
